Minjing Zhao
600 Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
MRI-Based Synovial Iron Quantification Associates with Bone Erosion in Rheumatoid Arthritis.
Journal: Biomedicines
Published: February 05, 2026
Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial.
Journal: Frontiers in immunology
Published: June 13, 2022
Seronegative rheumatic arthritis has milder inflammation and bone erosion in an ultrasound study of disease-modifying anti-rheumatic drugs (DMARDs)-naïve Chinese cohort.
Journal: Annals of translational medicine
Published: April 07, 2022
Ataxia-televangelist mutated (ATM)/ ATR serine/threonine kinase (ATR)-mediated RAD51 recombinase (RAD51) promotes osteogenic differentiation and inhibits osteoclastogenesis in osteoporosis.
Journal: Bioengineered
Published: February 18, 2022
Overexpressed RAD51 promoted osteogenic differentiation by activating IGF1R/PI3K/AKT pathway in osteoblasts.
Journal: Acta biochimica Polonica
Published: November 19, 2021
TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis.
Journal: Arthritis research & therapy
Published: January 22, 2020
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.
Journal: Frontiers in pharmacology
Published: October 15, 2019
Using Mobile Apps for Health Management: A New Health Care Mode in China.
Journal: JMIR mHealth and uHealth
Published: March 06, 2018
Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis.
Journal: International journal of rheumatic diseases
Published: October 31, 2017
Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: a three years' following-up study.
Journal: Clinical rheumatology
Published: March 18, 2017
Effects and safety of 99Tc-MDP in patients with refractory ankylosing spondylitis: a 2-stage (30-week follow-up) clinical trial.
Journal: Clinical and experimental rheumatology
Published: March 10, 2017
Backfill is a specific sign of axial spondyloarthritis seen on MRI.
Journal: Joint bone spine
Published: February 12, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026